Filing Flows › Ocular Therapeutix (OCUL) › Stock forecast & fair value
Ocular Therapeutix (OCUL) stock forecast and price target
Ocular Therapeutix (OCUL) trades at $6.59. 11 analysts' median price target is $27.00 (+309%), from $14.00 to $34.00.
Ocular Therapeutix's latest quarter
Ocular Therapeutix, Q2 2026: revenue $13.5M (+0.1% year over year), operating margin -609.3%, net loss $78.8M, operating cash flow −$67.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for OCUL stock?
The median of 11 analysts' 12-month targets is $27.00, +309% from $6.59; the range is $14.00 to $34.00. The average rating is strong buy.
Does Ocular Therapeutix usually beat earnings estimates?
It beat the consensus EPS estimate in 50% of the quarters on record.
Is OCUL stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.